Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinwang Duan

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Clinical Rheumatology|June 29, 2021
Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO RegistryLixi Zhang, Huiyi Zhu, Pinting Yang, et al.
Arthritis Research & Therapy|January 12, 2021
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosusYirong Xiang, Mengtao Li, Hui Luo, et al.
Journal of the American Academy of Dermatology|July 13, 2025
The Prospective Registry Of MyositIS (PROMIS): II. Temporal shifts in causes of death among patients with idiopathic inflammatory myopathiesChen Yu, Chanyuan Wu, Shangyi Jin, et al.
Med (New York, N.Y.)|July 11, 2024
Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohortYufang Ding, Yangzhong Zhou, Feng Zhan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2021
Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort StudyJingge Qu, Mengtao Li, Yanhong Wang, et al.
Medcomm|November 17, 2025
Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort StudyYufang Ding, Mucong Li, Wei Bai, et al.
RMD Open|November 23, 2023
Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosusHanxiao You, Jiuliang Zhao, Miaojia Zhang, et al.
JAMA Network Open|May 8, 2026
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical TrialJian Zhu, Cheng Zhao, Cundong Mi, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
Annals of the Rheumatic Diseases|November 27, 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Clinical Rheumatology|June 29, 2021
Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO RegistryLixi Zhang, Huiyi Zhu, Pinting Yang, et al.
Arthritis Research & Therapy|January 12, 2021
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosusYirong Xiang, Mengtao Li, Hui Luo, et al.
Journal of the American Academy of Dermatology|July 13, 2025
The Prospective Registry Of MyositIS (PROMIS): II. Temporal shifts in causes of death among patients with idiopathic inflammatory myopathiesChen Yu, Chanyuan Wu, Shangyi Jin, et al.
Med (New York, N.Y.)|July 11, 2024
Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohortYufang Ding, Yangzhong Zhou, Feng Zhan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2021
Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort StudyJingge Qu, Mengtao Li, Yanhong Wang, et al.
Medcomm|November 17, 2025
Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort StudyYufang Ding, Mucong Li, Wei Bai, et al.
RMD Open|November 23, 2023
Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosusHanxiao You, Jiuliang Zhao, Miaojia Zhang, et al.
JAMA Network Open|May 8, 2026
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical TrialJian Zhu, Cheng Zhao, Cundong Mi, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
Annals of the Rheumatic Diseases|November 27, 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Ying Jiang, Shangzhu Zhang, et al.
Pageof 8